Position in AZN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$35,399,399
-$3,218,249 QoQ
Shares Held
186,686
-4.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#180
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANQUE PICTET & CIE SA holds $370,874,778 across 8 Drug Manufacturers - General names. AZN ranks #5 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
409,324 | $103,002,291 | |
| 2 | LLY |
ELI LILLY & Co
|
67,095 | $80,475,762 | |
| 3 | MRK |
Merck & Co., Inc.
|
503,429 | $64,690,626 | |
| 4 | JNJ |
Johnson & Johnson
|
173,057 | $43,951,286 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
186,686 | $35,399,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
199,740 | $25,235,151 | |
| 7 | BIIB |
Biogen Inc.
|
65,080 | $14,061,184 | |
| 8 | NVO |
Novo Nordisk A S
|
84,670 | $4,059,079 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,399,399 | 186,686 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $38,617,648 | 195,810 | Shares | Sole | 2026-04-14 | |
| No filing history on record for this holder in this stock. | ||||||